This article provides insights into the status, regulatory considerations, and delivery methods of gene therapy and genome editing technologies. It discusses approved gene therapies in the US, human genome editing in clinical applications, and the regulatory authority of the FDA over gene therapy. T

2 views • 27 slides

This initiative in Sarawak focuses on simplifying the business licensing process through regulatory experiments aimed at reducing regulatory burdens and improving the overall business ecosystem. By implementing innovative strategies such as risk-based approvals and composite licenses, the goal is to

0 views • 7 slides

The regulatory framework of SMEs, particularly within the Iberoamerican Network of Guarantees (REGAR), showcases the establishment and operations of guarantee schemes in various countries such as Spain, Mexico, Portugal, and others. The warranty industry has witnessed global expansion with diverse m

1 views • 17 slides

The Regulatory Update presented by Mark Foy, Chief Executive, and Chief Nuclear Inspector at the ONR NGO Forum highlighted key areas of focus including ethics, future strategies, and regulatory advancements in the nuclear industry. The forum also featured insights from Donald Urquhart, Executive Dir

3 views • 26 slides

Explore the comprehensive planning drivers, regulatory challenges, and implementation pathways in the environmental protection domain. Key elements include the strategic roadmap, funding priorities, regulatory analysis, and collaborative permitting strategies. Navigate the complexities of environmen

3 views • 11 slides

Guam's Regulatory Aquifer Mapping includes conflicting maps from USEPA, the Northern Guam Lens Study, and Groundwater Protection Zones, impacting land use regulations and water quality standards. Issues arise from inconsistencies in regulatory tools and language errors within the protection zones. Z

2 views • 19 slides

In today's rapidly evolving global trade landscape, the logistics industry is no stranger to constant regulatory changes. These changes not only affect operational procedures but also have a significant impact on cargo pricing technology. As revenue technology services continue to innovate to meet t

6 views • 5 slides

In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th and 15th of October 2024.\n\nRegister Now @ \/\/events.marketsandmarkets.com\/european-medical-devic

1 views • 6 slides

The co-chairs of the Task Force on Regulatory Fitness for Automated Driving Systems presented an informal document at the 19th meeting of GRVA, outlining the context, purpose, and status of regulations related to automated vehicles. The report focuses on the need for a regulatory environment for aut

1 views • 10 slides

Explore Kurt Lewin's Change Management Model, its key components, implementation strategies, and the factors that contribute to the success or failure of change initiatives. Learn about Kurt Lewin's background, Lewin's Golden Rules for Change, common barriers to change, and the essential factors tha

0 views • 50 slides

This Safety Guide aims to assist regulatory bodies in managing regulatory experience by identifying sources, establishing means for information exchange, and implementing record-keeping processes. It addresses the need for cooperation and knowledge sharing among regulatory bodies to enhance safety s

1 views • 9 slides

The BVIs FinTech Regulatory Sandbox aims to promote efficiencies, leverage technology for innovative financial solutions, provide regulatory clarity, and develop targeted responses. Eligible persons include startups proposing new financial services, innovative technologies for licensable services, a

2 views • 16 slides

Update on COVID-19 vaccine regulatory status as of January 25, 2021, provided by Dr. B. Semete-Makokotlela, SAHPRA CEO. The update includes information on vaccine applications submitted to SAHPRA, regulatory reviews conducted, and Section 21 applications for vaccines like Janssen, AstraZeneca, and C

1 views • 13 slides

The Regulatory Advisory Panel meeting held on October 14, 2020, at 3:30 p.m. covered roll call details of attendees from various organizations and agencies. The meeting focused on key members and workgroup organizations pertaining to health care, hospice, and regulatory affairs. Attendees were urged

0 views • 37 slides

The discussion at the ISPOR Annual Meeting focused on defining regulatory-grade real-world data (RWD) sources as those of adequate quality for specific regulatory purposes. Panelists emphasized the importance of authenticity, transparency, accuracy, and track record in evaluating data quality. They

2 views • 5 slides

This presentation to the Portfolio Committee on Mineral Resources and Energy delves into the Basic Fuel Price (BFP) for liquid fuels, covering global fuel pricing forms, policy positions, key pricing mechanisms, regulatory mandates, and the intricate structure behind fuel prices. It explains how the

2 views • 28 slides

The Change Curve Model, developed by Elisabeth Kubler-Ross, helps individuals navigate the stages of change by addressing denial, anger, bargaining, depression, and acceptance. This model provides a framework to understand different reactions to change and offers strategies to support individuals th

0 views • 4 slides

This session delves into the regulatory landscape focusing on the objectives, types, and origins of regulations in the financial sector, particularly in Nigeria. It discusses the essential role of regulation in promoting compliance, protecting stakeholders, and maintaining operational integrity with

1 views • 42 slides

Hana Lee, Ph.D., presents a webinar on the Targeted Learning Framework for Causal Effect Estimation using Real World Data (TMLE). The project aims to help the FDA develop a structured approach to incorporating real-world data into regulatory decision-making. TMLE offers a systematic roadmap aligned

0 views • 27 slides

NAMFISA, established under the NAMFISA Act of 2001, exercises supervision over financial institutions and services in Namibia. The organization recently underwent an organizational restructuring to optimize resources and enhance efficiency. They oversee a broad regulatory scope covering various fina

0 views • 25 slides

The regulatory update introduces the revision of Annex 1 by Greg McGurk on June 13th, 2018, emphasizing the history, process, and rationale for the revision. Key stakeholders, including regulatory bodies and industry players, are outlined, showcasing the global impact and need for alignment with cur

0 views • 36 slides

This presentation by the Council for the Built Environment (CBE) outlines the Identification of Work (IDoW) Policy, elucidating key regulatory mechanisms, acronyms, definitions, and the role of the CBE in implementing and evaluating such mechanisms in the built environment sector. The purpose is to

0 views • 28 slides

Learn about regulatory inspections, what to expect, and how to achieve the best outcomes in this comprehensive guide. Explore key areas reviewed, post-inspection engagement strategies, corporate strategies vs regulatory outcomes, and practical tips for handling inspections effectively.

0 views • 12 slides

The regulatory landscape for in-house solicitors engaging in pro bono work presents challenges and opportunities. While there are few restrictions on their practice, navigating SRA rules and obtaining clarity on pro bono activities can be complex. Available regulatory guidance covers statutory rules

1 views • 10 slides

The Kubler Ross Change Curve Model delineates five stages - Decision, Denial, Frustration, Depression, and Experiment - illustrating individual responses to organizational change. Recognizing these stages aids organizations in anticipating and managing employee reactions effectively. Each phase invo

0 views • 4 slides

The study examines the financial impact of the implementation of Solvency II in the Mexican insurance sector, focusing on differences between foreign and domestic insurance companies. Data from 92 insurance companies over a period from 2003 to 2018 is analyzed to evaluate changes in performance metr

0 views • 16 slides

Regulatory enzymes play a crucial role in controlling the activity of biochemical pathways by responding to the presence of specific molecules. They regulate the pathway's activity, ensuring that products are produced in the required amounts at different times. This article delves into the significa

5 views • 22 slides

The Protecting our Infrastructure of Pipelines and Enhancing Safety Act of 2016 authorizes funding for PHMSA. Information on rulemakings can be found in DOT reports. The timeline for future rulemaking is pending on implementing Executive Orders. Enforcing the Regulatory Reform Agenda aims to allevia

1 views • 79 slides

This information provides insights into the organizational structure and functions of the FDA Office of Regulatory Affairs (ORA) and the Office of Regulatory Science (ORS). It includes organizational charts, details about ORA laboratory locations, and the local structure of an ORA laboratory. Additi

1 views • 31 slides

Delve into the details of the Change Management Committee Meeting held on April 13, 2022. Explore topics such as change budgeting, horizon planning, budget vs. spend analysis, change pipeline, and development and delivery pipeline. Get an overview of the 2021-2022 DSC change and MiR pipeline, as wel

0 views • 55 slides

Regulation aims to correct market failures for societal welfare, but regulatory capture by interest groups can hinder regulatory actions. This work discusses economic theories on regulatory capture, forms of capture, and strategies to mitigate risks, emphasizing the public interest theory as a promo

0 views • 29 slides

Protecting consumers and investors through effective regulation of accounting and corporate financial reporting is crucial. Regulatory cooperation offers benefits like simplifying the regulatory environment and enforcing best practices. However, regulatory competition can uncover limits and the adva

1 views • 39 slides

The Victorian Regulatory Change Measurement (RCM) methodology introduced in June 2010 aims to measure reductions in regulatory burden through different categories such as administrative costs, substantive compliance costs, delay costs, and more. The RCM formula helps in calculating the total regulat

0 views • 63 slides

Discover the importance of building change competency and the keys to successful change management. Explore why change competency is crucial for organizational success, along with strategies for managing change effectively. Learn about different change management approaches and the benefits of a pro

0 views • 25 slides

The Change Management Committee Meeting on 9th March 2022 discussed the DSC Change Budget, Horizon Planning, Budget vs. Committed Spend, Change Pipeline, and Change Development & Delivery Pipeline, with insights on budget allocation and project progress. New Change Proposals like XRN5482 for meter a

0 views • 61 slides

Start/end date for WP5.1 initiative is M7-M24, led by CONFAGRI.PT and partners. The project aims to prepare the roll-out of deliverables at national and regional levels, focusing on regulatory frameworks, sustainability plan, and stakeholder engagement. Various organizations contribute to provide EU

0 views • 7 slides

Elasticity of demand refers to the responsiveness of quantity demanded to changes in price. Perfectly elastic demand occurs when there is an infinite demand at a particular price and demand becomes zero with a slight rise in price. Conversely, perfectly inelastic demand occurs when there is no chang

0 views • 11 slides

This article explores the adoption of Regulatory Impact Assessment (RIA) in India, discussing the political economy challenges and strategies to overcome roadblocks. It outlines the working definition of RIA, addresses potential opposition from politicians and bureaucrats, and suggests ways to gener

0 views • 7 slides

Good Regulatory Practice (GRP) is a key aspect of regulatory policy that focuses on improving the quality and cost-effectiveness of domestic regulations. It involves internationally recognized processes such as impact assessment, regulatory transparency, participation, and accountability. The import

0 views • 22 slides

The executive review delves into regulatory materials from various chapters, highlighting both successes and failures within the regulatory landscape. It explores the tension in rulemaking, public perception of risk, and the role of non-agency regulation in tort and compensation law. The discussion

0 views • 44 slides